Sanofi, Stanford Form Alliance
Paris-based drug giant Sanofi-Aventis (NYSE: SNY) said today it has formed a multi-year research collaboration with Stanford University’s Bio-X program. Under the deal, a joint steering committee from both organizations will agree on funding terms for as many as five projects a year, according to a statement. Sanofi may also host postdoctoral fellows from Stanford, while Stanford faculty may invite Sanofi scientists to be visiting scholars to pursue research work on campus. Details on finances weren’t disclosed in today’s statement.